(Date:12/14/2009)... Scientific Corporation (NYSE: BSX ) today announced ... aggregate principal amount of its senior notes under the ... of $850 million of 4.50 percent notes due January ... 2020 and $300 million of 7.375 percent notes due ... net proceeds for general corporate purposes, including prepaying its ...
(Date:12/14/2009)... , - Results From ... Rheumatoid Arthritis in Seven Major Industrialized Countries , , ... arthritis say their disease, impacts ... Women living with rheumatoid arthritis find shopping for gifts, ... wrapping presents most, difficult to ...
(Date:12/11/2009)... researchers have observed the "hot electron" effect in a ... the elusive charges using ultra-thin solar cells, opening a ... report in the current online edition of Applied ... solar cells, it generates free electrons in a range ... charges, the electrons must reach the bottom of the ...
(Date:12/11/2009)... Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" or the ... Warrander to the role of Senior Vice President, ... will be responsible for the execution of the ... Thompson, President and CEO of Oncolytics. "Having reached ... 3 trial examining REOLYSIN in combination with paclitaxel ...
Breaking Biology Technology:Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Elusive 'hot' electrons captured in ultra-thin solar cells 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3... TELK ) announced that company management will provide ... Biotechnology and Medical,Technology Conference in New York City on ... a.m. Pacific time). A live and archived webcast of,the ... ., Telik, Inc. of Palo Alto, CA, is ...
... Boston Scientific,Corporation (NYSE: BSX ) is scheduled to ... held June 9-12 in Dana Point,CA., Jim Tobin, ... which will be followed by a 25-minute question and,answer ... a.m.,PT., A live webcast of Mr. Tobin,s remarks ...
... - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today ... Phase II clinical trial using intravenous,administration of REOLYSIN(R) ... advanced head and neck cancers. The principal,investigator is ... Research,and The Royal Marsden NHS Foundation Trust., ...
Other Biology Technology:Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 2... contains the basic components required for the ... and recombinant rat Thymus Chemokine-1 in cell ... sufficient materials to run ELISAs on approximately ... conditions are met: The assay ...
FGF Receptor 1 Antibody...
Immunogen: Purified native p24 from strain IIIB. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse Anti-human CD11b/Mac-1alpha, clone LM2/1, Monoclonal Antibody...
Biology Products:Biology NavigationMedical Navigation